JOHN M LEONARD

CIK 1563584 · President and CEO · last filed 2026-04-27

JOHN M LEONARD is a President and CEO who has filed 66 SEC Form 4 insider transactions across 6 companies since 2013. The most recent filing, for IQV, was dated Apr 27, 2026. Across all open-market trades the lifetime net is −$60.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $44.6M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$44.57M

Companies

6

Total Filings

66

Lifetime Open-Market Net

-$60.48M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
IQV Director 16,946 $181.46 $3.08M -$3.09M 10 2026-04-27
NTLA President and CEO 1,228,154 $12.11 $14.87M -$54.68M 38 2026-03-03
CHIMERIX INC (CMRX) Delisted Director 4,000 $8.54 $34.2K $138.2K 6 2017-06-29
Q Director 4,702 $150.65 $708.4K $0 4 2017-05-25
Vitae Pharmaceuticals, Inc (VTAE) Delisted Director $0 3 2016-10-25
ABBV SVP, Chief Scientific Officer 113,793 $227.73 $25.91M -$2.84M 5 2013-03-19

Recent Filings

66 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-04-27 IQV Grant (A) +1,571 $0 EDGAR
2026-03-03 NTLA Grant (A) +156,400 $0 EDGAR
2026-01-07 NTLA Sell (S) −34,146 -$314.5K EDGAR
2025-12-12 NTLA Mixed −29,630 -$436.7K EDGAR
2025-04-25 IQV Grant (A) +1,592 $0 EDGAR
2025-03-04 NTLA Grant (A) +136,000 $0 EDGAR
2025-01-07 NTLA Sell (S) −26,807 -$326.5K EDGAR
2025-01-03 NTLA Exer (M) +7,850 $0 EDGAR
2024-05-09 IQV Grant (A) +1,047 $0 EDGAR
2024-03-05 NTLA Grant (A) +113,586 $0 EDGAR
Showing 110 of 66
Page 1 of 7
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.